Description
Introduction Of Versavo 400mg Infusion:
Versavo 400mg Infusion is a monoclonal antibody anti-cancer medicine used in the treatment of metastatic colorectal cancer, non-small cell lung cancer, kidney cancer, cervical cancer, metastatic breast cancer, glioblastoma (a type of brain tumour), and epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Versavo 400mg Infusion is given as an intravenous infusion by a qualified healthcare professional after dilution; it should not be self-administered. Your doctor will decide the dose and treatment schedule based on your medical condition, often using it alongside other chemotherapy medicines. Women of childbearing potential should use effective contraception during treatment and for at least six months after the last dose, as this medicine can harm an unborn baby. Maintain all your scheduled appointments, as continuing the course as advised is important for consistent results.
Nausea and weakness are among the most common effects of this medicine. Your doctor will monitor your blood pressure and urine protein levels regularly during treatment. Inform your doctor immediately if you notice severe stomach pain, unusual bleeding, wounds that will not heal, or sudden shortness of breath, as this medicine can rarely affect blood vessel and wound healing.
Uses Of Versavo 400mg Infusion:
- Metastatic colorectal cancer
- Non-small cell lung cancer
- Kidney cancer (renal cell carcinoma)
- Cervical cancer
- Metastatic breast cancer
- Epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Glioblastoma (brain tumour)
Benefits Of Versavo 400mg Infusion:
1. Colorectal, lung, kidney, and cervical cancer
These cancers occur when abnormal cells grow uncontrollably in different parts of the body, often relying on new blood vessels to receive oxygen and nutrients needed for growth. Versavo 400mg Infusion works by blocking vascular endothelial growth factor (VEGF), a protein responsible for the formation of these new blood vessels within tumours, thereby limiting the tumour’s oxygen and nutrient supply and helping it shrink or stop growing.
2. Breast, ovarian cancer, and glioblastoma
Breast cancer, ovarian cancer, and glioblastoma also depend heavily on new blood vessel formation to support tumour growth and spread. Versavo 400mg Infusion, often used alongside chemotherapy, helps starve these tumours of their blood supply, helping control the disease and slow its progression.
Side effects of Versavo 400mg Infusion:
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common side effects of Versavo:
- Nausea
- Vomiting
- Weakness
- Diarrhea
- Stomach pain
- Loss of appetite
- Constipation
- Fever
- Nosebleeds
- Change in speech or taste
- High blood pressure
Mechanism Of Action Of Versavo 400mg Infusion:
Versavo Infusion contains Bevacizumab, a monoclonal antibody that works against vascular endothelial growth factor (VEGF), a protein found on the lining of blood and lymph vessels. VEGF normally causes new blood vessels to grow within tumours, supplying them with oxygen and nutrients. By inhibiting VEGF, Versavo limits the flow of oxygen and nutrients to the tumour, causing it to shrink or stop growing, thereby helping treat various types of cancer.

Reviews
There are no reviews yet.